People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RaNA Therapeutics, LLC | — | Biotechnology | Series C | $63.8M | $2.6B | 2015 |
| RaNA Therapeutics, Inc. | — | Biotechnology | Seed | $2.7M | $118.3M | 2011 |
Brian Francois Gallagher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Francois Gallagher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jean-Francois Formela | 2 | 17 |
| Mitchell S. Bloom | 1 | 7 |
| RONALD C. RENAUD JR. | 1 | 5 |
| Arthur M. Krieg | 1 | 2 |
| Robert C. Prentiss | 1 | 1 |
| Daniel Francois Lynch | 1 | 1 |
| Steve S. Padgette | 1 | 1 |
| Ankit S. Mahadevia | 1 | 1 |
| Joshua Francois Resnick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.